Company’s CEO, board members, other C-suite members, and institutional and accredited investors are participants in the extension of the bridge financing SAN FRANCISCO, CA / ACCESS Newswire / June 24, ...
Indaptus Therapeutics announces $2.3 million from convertible promissory notes, seeking total $5 million for R&D and operations. Indaptus Therapeutics, Inc. announced the sale of approximately $2.3 ...
Toronto, Ontario--(Newsfile Corp. - September 11, 2025) - Roscan Gold Corporation (TSXV: ROS) (FSE: 2OJ) (OTCQB: RCGCF) ("Roscan" or the "Company") announces that, further to its press release of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback